Research Paper Volume 15, Issue 17 pp 8664—8691
Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
Figure 3. Associations between KIAA1429 expression and tumor mutational burden (TMB), microsatellite instability (MSI). (A) Correlations between KIAA1429 expression and TMB in pan-cancer. (B) Correlations between KIAA1429 expression and MSI in pan-cancer.